116 related articles for article (PubMed ID: 35204900)
1. The Role of Glucocorticoids in the Treatment of Multisystem Inflammatory Syndrome (MIS-C)-Data from POLISH MIS-C Registry.
Gowin E; Toczyłowski K; Sulik A; Wysocki J; Januszkiewicz-Lewandowska D
Children (Basel); 2022 Feb; 9(2):. PubMed ID: 35204900
[TBL] [Abstract][Full Text] [Related]
2. A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome.
Devrim İ; Böncüoğlu E; Kıymet E; Şahinkaya Ş; Çelebi MY; Cem E; Düzgöl M; Arıkan KÖ; Kara AA; Besin D; Vuran G; Seven P; Meşe T; Ağın H; Bayram N
Pediatr Rheumatol Online J; 2022 Aug; 20(1):69. PubMed ID: 35987681
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study.
Dizon BLP; Redmond C; Gotschlich EC; Sule S; Ronis T; Vazzana KM; Sherman MA; Connor R; Bosk A; Dham N; Harahsheh AS; Wells E; DeBiasi R; Srinivasalu H
Pediatr Rheumatol Online J; 2023 Jul; 21(1):76. PubMed ID: 37525200
[TBL] [Abstract][Full Text] [Related]
4. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
Son MBF; Murray N; Friedman K; Young CC; Newhams MM; Feldstein LR; Loftis LL; Tarquinio KM; Singh AR; Heidemann SM; Soma VL; Riggs BJ; Fitzgerald JC; Kong M; Doymaz S; Giuliano JS; Keenaghan MA; Hume JR; Hobbs CV; Schuster JE; Clouser KN; Hall MW; Smith LS; Horwitz SM; Schwartz SP; Irby K; Bradford TT; Maddux AB; Babbitt CJ; Rowan CM; McLaughlin GE; Yager PH; Maamari M; Mack EH; Carroll CL; Montgomery VL; Halasa NB; Cvijanovich NZ; Coates BM; Rose CE; Newburger JW; Patel MM; Randolph AG;
N Engl J Med; 2021 Jul; 385(1):23-34. PubMed ID: 34133855
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and outcome of MIS-C patients: an experience from Central Anatolia.
Alkan G; Sert A; Oz SKT; Emiroglu M; Yılmaz R
Clin Rheumatol; 2021 Oct; 40(10):4179-4189. PubMed ID: 33956250
[TBL] [Abstract][Full Text] [Related]
6. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
Zhang QY; Xu BW; Du JB
World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar.
Hasan MR; Al Zubaidi K; Diab K; Hejazi Y; Bout-Tabaku S; Al-Adba B; Al Maslamani E; Janahi M; Roscoe D; Lopez AP; Tang P
BMC Pediatr; 2021 Jun; 21(1):267. PubMed ID: 34103044
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory Therapy for MIS-C.
Ouldali N; Son MBF; McArdle AJ; Vito O; Vaugon E; Belot A; Leblanc C; Murray NL; Patel MM; Levin M; Randolph AG; Angoulvant F;
Pediatrics; 2023 Jul; 152(1):. PubMed ID: 37376963
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Biologics in the Treatment of Multisystem Inflammatory Syndrome in Children (Mis-C): A Single-Center Propensity-Score-Matched Study.
Basaran O; Batu ED; Kaya Akca U; Atalay E; Kasap Cuceoglu M; Sener S; Balık Z; Karabulut E; Kesici S; Karagoz T; Ozsurekci Y; Bilginer Y; Cengiz AB; Ozen S
Children (Basel); 2023 Jun; 10(6):. PubMed ID: 37371276
[TBL] [Abstract][Full Text] [Related]
10. The "Golden Hours" Algorithm For the Management of the Multisystem Inflammatory Syndrome in Children (MIS-C).
Mahmoud S; Fouda EM; Kotby A; Ibrahim HM; Gamal M; El Gendy YG; Zaky EA; Amr NH; El-Ghoneimy DH; Alsharkawy AA; Omar A; El-Meteini M; Elhodhod M
Glob Pediatr Health; 2021; 8():2333794X21990339. PubMed ID: 33614843
[TBL] [Abstract][Full Text] [Related]
11. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
Burns JC; Roberts SC; Tremoulet AH; He F; Printz BF; Ashouri N; Jain SS; Michalik DE; Sharma K; Truong DT; Wood JB; Kim KK; Jain S;
Lancet Child Adolesc Health; 2021 Dec; 5(12):852-861. PubMed ID: 34715057
[TBL] [Abstract][Full Text] [Related]
12. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
[TBL] [Abstract][Full Text] [Related]
13. Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean.
Ozsurekci Y; Gürlevik S; Kesici S; Akca UK; Oygar PD; Aykac K; Karacanoglu D; Sarıtas Nakip O; Ilbay S; Katlan B; Ertugrul İ; Cengiz AB; Basaran O; Cura Yayla BC; Karakaya J; Bilginer Y; Bayrakci B; Ceyhan M; Ozen S
Clin Rheumatol; 2021 Aug; 40(8):3227-3237. PubMed ID: 33576926
[TBL] [Abstract][Full Text] [Related]
14. IVIG Compared With IVIG Plus Infliximab in Multisystem Inflammatory Syndrome in Children.
Cole LD; Osborne CM; Silveira LJ; Rao S; Lockwood JM; Kunkel MJ; MacBrayne CE; Heizer HR; Anderson MS; Jone PN; Dominguez SR
Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34548377
[TBL] [Abstract][Full Text] [Related]
15. IVIG plus Glucocorticoids versus IVIG Alone in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Systematic Review and Meta-Analysis.
Rauniyar R; Mishra A; Kharel S; Giri S; Rauniyar R; Yadav S; Chaudhary G
Can J Infect Dis Med Microbiol; 2022; 2022():9458653. PubMed ID: 35368517
[TBL] [Abstract][Full Text] [Related]
16. An Arab Adolescent with Multisystem Inflammatory Syndrome Associated with COVID-19: A Report from Syria.
Zaino J; Bakri A; Al Sayed Ahmad A; Hadba G
Avicenna J Med; 2021 Oct; 11(4):221-224. PubMed ID: 34881206
[TBL] [Abstract][Full Text] [Related]
17. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
[TBL] [Abstract][Full Text] [Related]
18. Early Treatment of Multisystem Inflammatory Syndrome in Children.
Jonat B; Geneslaw AS; Capone CA; Shah S; Bartucca L; Sewell TB; Acker KP; Mitchell E; Cheung EW
Pediatrics; 2023 Sep; 152(3):. PubMed ID: 37534417
[TBL] [Abstract][Full Text] [Related]
19. A 7-Year-Old Boy and a 14-Year-Old Girl Initially Diagnosed with Toxic Shock Syndrome and Tested Positive for SARS-CoV-2 Infection, Supporting a Diagnosis of Multisystem Inflammatory Syndrome in Children (MIS-C).
Giordano S; Failla MC; Li Cavoli MG; Romano D; Vanella V; Caruso C; Chillura I; Maggio MC
Am J Case Rep; 2021 Oct; 22():e931570. PubMed ID: 34635631
[TBL] [Abstract][Full Text] [Related]
20. Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in Children.
Chang JC; Young CC; Muscal E; Sexson Tejtel SK; Newhams MM; Kucukak S; Crandall H; Maddux AB; Rowan CM; Halasa NB; Harvey HA; Hobbs CV; Hall MW; Kong M; Aguiar CL; Schuster JE; Fitzgerald JC; Singh AR; Wellnitz K; Nofziger RA; Cvijanovich NZ; Mack EH; Schwarz AJ; Heidemann SM; Newburger JW; Zambrano LD; Campbell AP; Patel MM; Randolph AG; Son MBF;
Arthritis Rheumatol; 2023 Aug; 75(8):1466-1476. PubMed ID: 36908050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
